Probiotic Formulation Inhibits E. coli and C. albicans
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for Urinary Tract Infections (UTIs) and Vaginal Candidiasis (VC) are inadequate, with conventional antimicrobials and antifungals showing limited effectiveness and potential for resistance, and non-antibiotic approaches like probiotics and cranberry products having minimal success in prevention and treatment.
Innovation Solution
A novel women's health probiotic formulation combining Bifidobacteria and Lactobacilli with cranberry powder in a sterilized liquid fruit and vegetable juice medium, which inhibits the growth of E. coli and C. albicans, the pathogens responsible for UTIs and VC, respectively, while maintaining viability and palatability.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional antimicrobials and antifungals are used to treat UTIs and VC, then infection treatment effectiveness is improved, but antimicrobial resistance develops and adverse reactions occur
Solution Approach 1:
The patent uses probiotics (Bifidobacteria and Lactobacilli) as intermediary organisms that compete with pathogenic bacteria for resources and attachment sites in the urinary tract. These beneficial bacteria produce bacteriocins and other antimicrobial substances that indirectly inhibit E. coli and C. albicans growth without directly killing them, thereby avoiding resistance development while maintaining treatment effectiveness
Solution Approach 2:
The patent converts the harmful overgrowth of pathogenic bacteria into a beneficial situation by introducing probiotics that outcompete the pathogens. The probiotics utilize the same nutrients and environmental conditions that support pathogen growth, but instead of allowing harmful bacteria to thrive, they promote beneficial bacterial colonization that naturally suppresses pathogenic organisms through competitive exclusion and production of inhibitory substances
2Object-affected harmful factors
If non-antibiotic approaches like probiotics and cranberry products are used, then adverse reactions are reduced, but prevention and treatment success is minimal
Solution Approach 1:
The patent creates a composite probiotic formulation combining multiple strains of Bifidobacteria (B. bifidum, B. breve, B. lactis, B. longum, B. infantis) and Lactobacillus (L. acidophilus, L. brevis, L. bulgaricus, L. casei, L. gasseri, L. paracasei, L. plantarum, L. reuteri, L. rhamnosus, L. salivarius) with cranberry powder. This multi-component composite provides synergistic effects where different bacterial strains contribute diverse mechanisms of action against pathogens, enhancing overall treatment success while maintaining safety
Solution Approach 2:
The patent merges probiotic bacteria with cranberry powder in a unified formulation. The cranberry components (proanthocyanidins, organic acids) work synergistically with the probiotic bacteria to enhance inhibition of E. coli and C. albicans. This combination approach consolidates multiple protective mechanisms into a single therapeutic agent, improving prevention and treatment success rates compared to single-component approaches
3Adaptability or versatility
If multiple probiotic strains are combined in a liquid medium, then inhibition of multiple pathogens is achieved, but formulation complexity increases
Solution Approach 1:
The patent develops a universal liquid probiotic formulation that simultaneously targets multiple pathogens (E. coli and C. albicans) affecting women's urinary and vaginal health. The same formulation containing diverse probiotic strains and cranberry components provides broad-spectrum protection against different types of infections, making it a multi-functional therapeutic solution that addresses both UTIs and VC with a single product
Solution Approach 2:
The patent optimizes the liquid medium parameters including pH, sugar content (5-15%), and nutrient composition to support the growth and survival of multiple probiotic strains simultaneously. By carefully controlling these physical and chemical parameters, the formulation maintains stability and efficacy of diverse bacterial strains without requiring complex formulation structures or additional stabilizing components
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The probiotic formulation effectively inhibits E. coli and C. albicans, providing a promising alternative to conventional treatments by maintaining the health of women suffering from UTIs and VC, with a pleasant taste and shelf-stable without refrigeration.
Implementation Method 1
probiotics or cranberry have had minimal success both in prevention and treatment
Implementation Method 2
The probiotic formulation effectively inhibits E. coli and C. albicans
Implementation Method 3
cranberry powder in fruit and liquid juices effective against both pathogens
Data Source
AI summary
The present invention is directed to a novel women's health probiotic formulation and methods of using the women's health probiotic formulation that inhibits both E. coli and C. albicans. Probiotics of the invention utilize Bifidobacteria and Lactobacilli to formulate a novel women's health probiotic comprising cranberry powder effective against both pathogens.